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Chondrocyte gene regulation is important for the generation and maintenance of cartilage tissues. Several regulatory
factors have been identified that play a role in chondrogenesis, including the positive transacting factors of the SOX
family such as SOX9, SOX5, and SOX6, as well as negative transacting factors such as C/EBP and delta EF1.
However, a complete understanding of the intricate regulatory network that governs the tissue-specific expression of
cartilage genes is not yet available. We have taken a computational approach to identify cis-regulatory, transcription
factor (TF) binding motifs in a set of cartilage characteristic genes to better define the transcriptional regulatory
networks that regulate chondrogenesis. Our computational methods have identified several TFs, whose binding
profiles are available in the TRANSFAC database, as important to chondrogenesis. In addition, a cartilage-specific
SOX-binding profile was constructed and used to identify both known, and novel, functional paired SOX-binding
motifs in chondrocyte genes. Using DNA pattern-recognition algorithms, we have also identified cis-regulatory
elements for unknown TFs. We have validated our computational predictions through mutational analyses in cell
transfection experiments. One novel regulatory motif, N1, found at high frequency in the COL2A1 promoter, was
found to bind to chondrocyte nuclear proteins. Mutational analyses suggest that this motif binds a repressive factor
that regulates basal levels of the COL2A1 promoter.
[Supplemental material is available online at www.genome.org.]
Gene expression and its regulation are important for the coordi-
nation of various activities of a cell. This complex regulatory
circuit involves a multitude of transcription factors (TFs) and
their corresponding cis-acting regulatory elements whose inter-
action in a variety of permutational and combinatorial events
enable the function and maintenance of tissues. An understand-
ing of the transcriptional regulatory network (Covert et al. 2004)
can be attempted using a computational approach in which
TF-binding sites can be modeled, searched, and identified in the
non-coding sequence through the use of position weight matri-
ces (PWMs) and DNA pattern recognition programs (Stormo
2000). The conservation of functional cis-acting elements among
the non-coding sequences of orthologous genes denoted by
“phylogenetic footprinting” has refined computational ap-
proaches to allow for a credible identification of cis-acting ele-
ments (Tagle et al. 1988; Wasserman et al. 2000; Blanchette and
Tompa 2002).
The successful use of DNA pattern recognition programs in
inferring regulatory circuits has been evident in the detection of
novel regulatory elements involved in heat-shock response
(GuhaThakurta et al. 2002a) and in foregut development (Ao et
al. 2004) in the nematode Caenorhabditis elegans. Position weight
matrix models and phylogenetic footprinting have also been
used to define transcriptional regulatory mechanisms in mam-
malian genomes (Qiu et al. 2003; Hu et al. 2004; Nelander et al.
2005; Chang et al. 2006). Such an approach to chondrocyte gene
regulation is of interest to add to the understanding of the gen-
eration and maintenance of cartilage and its influence on endo-
chondral bone formation derived from the cartilage anlagen
(Karsenty and Wagner 2002).
Many genes such as collagen type II (COL2A1), collagen type
IX (COL9A1), collagen type XI (COL11A2), and melanoma in-
hibitory activity (MIA) that are normally expressed predomi-
nantly and almost exclusively in cartilage are known to share
common regulatory factors (Okazaki et al. 2002; Okazaki and
Sandell 2004; Furumatsu et al. 2005; Imamura et al. 2005). This
suggests that there are common regulatory modules for cartilage-
specific genes that determine their expression pattern. The an-
notation of such sequences would help define the temporal and
tissue-specific expression pattern of these genes in chondrocytes.
Therefore, in this study, we have taken a computational ap-
proach in order to identify TF-binding motifs important to car-
tilage maintenance and development. Although several reports
have used computational methods to detect mammalian regula-
tory sequence or regulatory modules, only a few of them have
experimentally validated their predictions (Blanchette et al.
2006; Wang et al. 2006). In this report, we have successfully
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identified and validated several SOX-binding motifs that regu-
late chondrocyte-specific gene expression. We have also success-
fully identified several novel TF-binding motifs in our carti-
lage gene set. One of these motifs, N1, was found to bind nuclear
proteins, and mutational analyses suggest that it participates
in regulating at least three cartilage genes in our set. These
data point out the usefulness of computational approaches in
annotating functional regulatory motifs in mammalian ge-
nomes.
Results
Analyses of previously characterized TF-binding motifs
in cartilage characteristic genes
Our analyses included steps to identify known TF-binding mo-
tifs, novel binding motifs, and paired SOX-binding sites within
cartilage enhancer sequences by examining the conserved se-
quence in 18 orthologous pairs of human and mouse genes. The
results of the analysis of the characterized TF binding motifs from
TRANSFAC are shown in Table 1A. Transcription factor-binding
motifs were ranked by the log ratio of the probability scores,
taking into account multiple predicted binding sites within a
promoter, calculated using cartilage genes and background
genes, respectively (see Methods). Based on this model, a higher
log ratio value indicates a higher probability that the TF will
bind to the promoter of these cartilage genes. The log ratios of
the probability scores for TFs with documented roles in chondro-
genesis are given in Table 1B.
Identification of paired SOX-binding motifs in cartilage
characteristic genes
One TF we expected to detect with a high log ratio in the analyses
above is SOX9, a master regulator of chondrogenesis (Wagner et
al. 1994; Wheatley et al. 1996; Lefebvre et al. 1997; Ng et al. 1997;
Bi et al. 1999; Wegner 1999; Akiyama et al. 2002). However, the
log ratio values for both the TRANSFAC SOX9 and SOX5 motifs
in cartilage genes were relatively low compared to other motifs
(0.842 for SOX9 and 1.351 for SOX5) given the known functional
roles these factors play in vivo. SOX transcription factors bind to
cis-regulatory sequences through a conserved HMG domain. The
SOX subfamily of HMG proteins is remarkable as they appear to
play distinct and essential roles in many different developmental
processes, yet the DNA-binding sites they recognize are highly
degenerate. Their trans-activating functions and specificities ap-
pear to be highly dependent on both the orientation of, and the
spacing between, their binding sites and the binding sites of
other cofactors (Wegner 1999; Peirano and Wegner 2000; Bridge-
water et al. 2003). This suggests that the SOX motif present in
TRANSFAC may not model functional SOX-binding sites present
in chondrocyte genes precisely and accurately. Therefore, to bet-
ter model the binding sites involved in cartilage gene regulation,
we constructed a cartilage-specific SOX-binding profile from en-
hancer elements known to specify cartilage gene expression in
vivo (Fig. 1A,B). We collected a set of 31 previously documented
SOX-binding sites (Supplemental Table 1) from three cartilage-
specific genes. The consensus sequence of this profile is CTTT
GWW, which is slightly different from the TRANSFAC motifs for
SOX5 (ATTGTT) or SOX9 (CYATTGTT). These three SOX-binding
Figure 1. The position weight matrix and the sequence logo of the
cartilage-specific SOX-binding profile constructed from experimentally
validated SOX sites. Thirty-one experimentally validated SOX-binding
sites from three genes were collected from the literature and used to
model a SOX-binding profile for searching the cartilage gene set. (A) An
illustration of the position weight matrix developed using these sites.
(B) The sequence logo describing the position weight matrix (Schneider
and Stephens 1990). For sequences and species information, see Supple-
mental Table 1.
Table 1. Statistical analyses of significant transcription factor
binding sites in the cartilage gene set
A. Top-ranking transcription factors based on log(Pc/Pa) values
Motif ID Transcription factor Class Log(Pc/Pa)
M00131 HNF-3beta 3.3.2 4.209
M00289 HFH-3 3.3.0 3.353
M00731 Osf2 4.11.1 3.300
M00722 CBF 0.3.2 3.294
M00053 c-Rel 4.1.1 3.264
M00649 MAZ 2.3.0 3.204
M00720 CAC-binding 2.3.0 3.203
M00769 AML 4.11.1 3.161
M00188 AP-1 1.1.1 3.076
M00130 FOXD3 3.3.0 3.054
M00192 GR 2.1.1 3.044
M00724 HNF-3alpha 3.3.0 3.031
B. Other known transcription factors that are known to regulate or
potentially regulate cartilage genes
Motif ID Transcription factor Class Log(Pc/Pa)
M00415 AREB6 3.1.4 2.98
M00807 Egr 2.3.2 2.457
M00189 AP-2 1.6.1 2.266
M00074 c-Ets-1 3.5.2 2.034
M00033 p300 N/A 1.856
M00770 C/EBP 1.1.3 1.635
M00042 SOX-5 4.7.1 1.351
M00410 SOX-9 4.7.1 0.842
C. Novel binding motifs over-represented in the cartilage gene set
Motif ID Transcription factor Class Log(Pc/Pa)
N1 Unknown N/A 2.302
N20 Unknown N/A 2.292
N23 Unknown N/A 1.471
N24 Unknown N/A 2.597
N31 Unknown N/A 3.382
Putative binding site of known transcription factors in cartilage gene
promoters were identified by PATSER. The binding probabilities were
calculated based on the scores of the sites. The log(Pc/Pa) values are
logarithms of binding probabilities normalized using all the promoters in
the genome. The TRANSFAC classification of binding motif is indicated.
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profiles are short and contain degenerate positions. Therefore, to
reduce the false-positive discovery rate, we used evolutionary
conservation to search for SOX sites conserved in human and
mouse cartilage genes. This approach significantly decreased the
number of predicted SOX sites in cartilage-expressed genes (data
not shown).
To test the sensitivity of our SOX model, we used this motif
to predict experimentally identified SOX-binding sites in our
training set of cartilage regulatory regions of the Mia, Col2a1, and
Col11a2 genes (Fig. 2A–C). Although using the SOX profile to
identify the contributing SOX-binding sites seems circular, the
purpose of this test is to identify (1) any SOX site in the training
set that is significantly different from other SOX sites and (2)
additional unknown SOX sites in the known cartilage regulatory
regions. All of the sites used to train the motif were also predicted
from our search algorithm with the exception of one in the 183-
bp Mia gene promoter element, indicating that our search criteria
were functioning appropriately. When the orientation and
spacing of the predicted sites were examined, we found at least
one tandem pair of sites with opposite orientations, with a short
spacer sequence in between (3–8 bp), for each of the regulatory
elements used to develop our model motifs (Fig. 2A–C).
Multiple sites were predicted in the
183-bp element, located at 2251 to
2058 of the Mia promoter, an essential
part of the cartilage regulatory module
(Okazaki et al. 2006). Indeed, it has been
shown in previous studies that the E
class of SOX factors, which includes
SOX9, can exhibit homodimeric, coop-
erative DNA binding that is dependent
on closely spaced and oppositely ori-
ented binding sites (Peirano and Wegner
2000; Sock et al. 2003). Next, we
searched the entire Mia gene promoter
sequence to see if our algorithm could
predict a known SOX9-binding site at
410 (Xie et al. 1999). In addition to
predicting our previously identified
SOX9 binding site, a novel, closely
spaced, and oppositely orientated site
was identified immediately downstream
at 395 (Fig. 2D). We mutated both the
410 and 395 sites individually and
analyzed the effects using luciferase re-
porter constructs in transient transfec-
tion experiments in RCS cells (Fig. 3). As
previously reported, the full-length
2251-bp construct that is required for
cartilage-specific expression exhibited
strong activity (Xie et al. 1999). In con-
trast, the negative control construct
truncated to 401 bp (and missing
the 410 SOX9 site) had virtually no
activity. Mutation of two core nucleo-
tides in the newly identified motif at
395 bp similarly ablated activity
of the full-length promoter construct
(2251 bp) despite the presence of the
410 SOX9-binding site that has previ-
ously been characterized (Fig. 3) (Xie et
al. 1999). Thus, both the 410 and
395 sites appear to be equally essential to the full-length pro-
moter activity.
Figure 2. Computational prediction of cartilage regulatory elements. Weight matrices for the SOX-
and C/EBP beta binding sites were used to search functional cartilage enhancers. (A) The 183-bp Mia
(mouse) element located at 2251 to 2058. (B) Col2A1 48-bp intron enhancer (mouse).
(C) Col11A2 intron enhancer (mouse). (D) Mia proximal promoter (mouse). Colors represent motifs
and their orientations as follows. (Blue) SOX sites on the forward strand; (red) SOX sites on the reverse
strand; (green) C/EBP beta sites on the forward strand; (yellow) C/EBP beta sites on the reverse strand;
(purple) overlapping SOX sites in opposite orientation. Bold letters in any color represent C/EBP beta
motifs. Chondrocyte regulatory motifs containing SOX pairs and C/EBP beta are indicated by brackets.
Gray shaded area in D indicates that the sequence region is conserved at >60% between human and
mouse. (*) Sites mutated in transient transfections (410m) and (395m). T1 and T2 are statistical
thresholds for C/EBP beta and SOX sites, respectively.
Figure 3. Mutational analyses of computationally predicted paired
SOX-binding motifs in the Mia promoter. RCS cells were transiently trans-
fected (in triplicate experiments) with either the full-length Mia (2251
bp mouse) promoter (required for chondrogenic expression), truncated
promoter (401), or with mutations in the computationally predicted
SOX-binding motifs (CA to GG) (410m and 395m).
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Since experimental data suggested that pairing of SOX mo-
tifs is an important part of the chondrocyte regulatory module,
we refined our search criteria to include not just the conservation
between the mouse and human sequences, but also the close
positioning of the sites that are 3–8 bp apart. A summary of all
the conserved sites predicted in the promoters of all the searched
cartilage genes is shown in Supplemental Table 2. As the table
indicates, the conservation between human and mouse ortholo-
gous sequences significantly reduced the number of motifs that
would be predicted to be functional. There were only three genes
in our cartilage set (COL9A2, COMP, FGF18) that did not have
any conserved pair of SOX sites. To test the specificity of our
search criteria, we also collected the promoters of 13 previously
reported liver-specific genes (Krivan and Wasserman 2001) and
performed the exact same search. Only six of the 13 liver-specific
genes have conserved paired SOX sites in
their promoters (Supplemental Table 3).
In addition to SOX factors, our pre-
vious results have implicated the repres-
sor C/EBP beta as a TF that may work in
these regulatory sequences to restrict
cartilage gene expression (Okazaki et al.
2006). Therefore, we also used the C/EBP
beta binding profile in TRANSFAC
(M00109) to search the cartilage gene se-
quences to see if we could predict similar
functional cartilage regulatory modules
(Fig. 2). When the positions of both the
conserved SOX sites and C/EBP beta mo-
tifs were considered, we found that
seven of the 18 genes in our list pos-
sessed at least one of these putative regu-
latory modules containing both paired
SOX sites and C/EBP beta sites in close
proximity. When liver-specific genes
were searched, only two genes had a
similar regulatory module in their pro-
moters (Supplemental Table 3).
Since the SOX-binding module
seemed a predominant feature in our
gene set, we then decided to test these
predicted sites for functional activity in
another well-characterized cartilage
gene promoter, COL9A1, that is known
to be activated by SOX9 in chondrocytes
(Zhang et al. 2003) (Fig. 4). We found 10
conserved motifs in the 10-kb upstream
sequence for COL9A1. Six of these motifs
were in the proximal region that could
readily be tested using transfection re-
porter assays (Fig. 4A). Each site was in-
dividually mutated by 1–2 bp (CA to GG,
depending on the endogenous se-
quence) in COL9A1 p846Luc constructs
(Zhang et al. 2003) and tested for pro-
moter activity in the RCS cells (Fig. 4B,
M1–M6). Similar to the Mia gene pro-
moter, all mutations of the core CA to
GG resulted in nearly complete loss of
promoter activity in the RCS cells. Site 4,
represented by mutation M4, has previ-
ously been characterized and demon-
strated to bind SOX9 in electromobility gel shift assays (EMSA),
and also served as a positive control in these experiments (Zhang
et al. 2003). In contrast to the RCS cells, the mutations did not
have a significant effect on the promoter activity in the NIH3T3
cells, a fibroblast cell line that does not express SOX9 mRNA
(Zhang et al. 2003; Davies et al. 2004) (Fig. 4C). This suggested
that the newly identified SOX-binding motifs were tissue-specific
and each site is as functionally important to promoter activity as
site 4. A similar mutation in a nonconserved SOX site (M7) did
not have the same effect in RCS cells (Fig. 4B).
Identification of a novel motif N1 in cartilage-expressed genes
Although the TRANSFAC database curates ∼500 vertebrate TF-
binding profiles, there are estimated to be ∼2000 TF proteins in
Figure 4. Mutational analyses of predicted SOX-binding motifs in the COL9A1 promoter. (A) The
proximal promoter region of the COL9A1 human gene showing the conserved and computationally
predicted SOX-binding motifs underlined (M1–M7). Mutated nucleotides are indicated by capital
letters. RCS cells (B) or NIH3T3 cells (C) were transiently transfected (in triplicates) with the COL9A1-WT
promoter construct (p846) or with the p846 construct with mutations (CA to GG) in the predicted
SOX-binding motifs M1, M2, M3, M4, M5, M6, and M7.
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the human genome. Therefore, the binding profiles of many
TFs are still not available, and the computational analysis de-
scribed above using the TRANSFAC motifs may have missed
other chondrocyte cis-regulatory elements. To circumvent this
problem, we applied the DNA pattern rec-
ognition algorithm CONSENSUS (Stormo
and Hartzell 1989; Hertz and Stormo 1999)
to identify potential regulatory motifs in
chondrocyte genes that have not been
identified in TRANSFAC. The input data
set for CONSENSUS is the conserved se-
quences of the 18 cartilage genes. We ana-
lyzed the human and mouse sequence sets
separately and used the ALLR statistics
(Wang and Stormo 2003) to find nonredun-
dant candidate motifs that were conserved
between human and mouse and over-
represented in cartilage promoters. By this
procedure, 87 conserved motifs were iden-
tified. Comparison and consolidation be-
tween similar motifs generated 23 non-
redundant conserved motifs. The log ratio
of the probability scores was calculated for
each motif (Table 1C), and the sequence
logo for the five top ranking motifs that
are not present in the TRANSFAC database
is shown in Figure 5. The distribution of
all five novel motifs in cartilage-charac-
teristic genes and their genomic location is shown in Supplemen-
tal Table 4.
The location of the N1 motif in the promoter regions of
both the COL2A1 and COL11A2 genes made this motif a good
candidate for experimental validation of its function. The con-
sensus sequence determined for this motif is CCAGAGCCC. Sig-
nificantly, evolutionarily conserved N1 motifs were detected in
the proximal promoter region of 11 of the 18 cartilage genes
analyzed in both human and mouse (Table 2). In some genes,
multiple conserved N1 motifs were detected. For example, in the
COL2A1 promoter, four conserved N1 motifs were identified
within 1 kb (N-125/126, N-135, N-147, and N-991), and one
conserved N1 motif was identified at the +16 (N+16) position
relative to the transcriptional start site.
To assess the function of the N1 motif and to determine its
relevance in the regulation of chondrogenesis, oligonucleotides
(15 bp in length) were generated from the promoter sequences of
the cartilage genes in which this motif was recognized (see Table
2) and used as probes in electromobility gel shift assays using
nuclear extracts from the RCS cells to determine protein-binding
capacity (Fig. 6). Significantly, a major DNA–protein complex
with similar mobility was generated for all the 16 oligonucleo-
tides tested (Fig. 6, O1–O16, arrowhead), suggesting that these
protein–DNA complexes probably have an identical TF binding
to the N1 motif. In all of these cases, the binding could be com-
peted by the addition of nonradiolabeled oligonucleotides to the
reaction, demonstrating the specific nature of this binding. For
the oligonucleotides O6, O13, O14, and O16, an additional,
faster migrating complex (double arrowhead) was also observed,
suggesting additional TFs may bind to these sequences as well.
Four conserved N1 sites were identified in the COL2A1 promoter
within 1 kb from the transcription start site (O6, O7, O8, O9).
The N1 site at125/126 was found to be present on both strands
of the COL2A1 promoter sequence at the indicated positions.
Interestingly, this motif, CCCCGGAGCCC, partially overlaps a
previously identified EGR1 site (with overlap shown in bold/
underlined) that mediates repression of the COL2A1 gene by
interleukin 1 beta (IL1B) (Tan et al. 2003).
Figure 5. Sequence logos of computationally predicted novel motifs
over-represented in cartilage genes. These motifs were identified using
the program CONSENSUS, which searches for enriched motifs in the
cartilage-specific promoters.
Table 2. Distribution of the novel N1 motif in the cartilage gene set
Motif Sequence Genes Position Orientation
O1 cggTCCGGAGCCAgg ACAN 504 +
O2 cacCCCAGGGACCga ACAN 438 
O3 tggGCCAGGGCCAgt ACAN (COL11A1) 1602 +
O4 ccgCCCACAGCCAcc COL11A2 84 
O5 gggCCCAGAGCCCcc COL11A2 (FGF18, SOX9) 306 
O6 gacCCGGCAGCCCag COL2A1 16 
O7 gccCCCGGAGCCCgc COL2A1 126 
O8 ctGCCAGTGCCCgca COL2A1 147 
O9 ctgGCCAGGGCCGca COL2A1 991 +
O10 tcaCCCAAAGCCAtg COL9A1 9189 
O11 cgcCCCGCAGCCCct FGF18 293 +
O12 ctgACCAGAGTCCtg FGF18 862 +
O13 gggCACAGAGCTGcc HAPLN1 48 +
O14 gtgCCCTGAGCCCtg MATN1 (CILP) 1856 +
O15 ttCCCAGAGAGCcca MATN1 4994 
O16 gggGCCCGAGCCCgg IHH 769 +
The novel N1 motif was highly represented in the cartilage gene set. O1 to O16 represent 15-mer
oligonucleotides containing the N1 motif that were generated for electromobility gel shift assays.
The predicted motifs are indicated in bold with the corresponding gene and location on their
respective promoters indicated (given in base pairs from the annotated transcription start site of the
first gene listed). The direction of orientation is listed in the last column with “+” corresponding to
the sense strand and “”corresponding to the antisense strand of the DNA.
Davies et al.
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To test the functional significance of the N1 motif in the
COL2A1 gene and validate the computational search, a muta-
tional analysis of the N1 motif was performed. To avoid compli-
cations in the analysis caused by the binding of other factors to
the site at 125/126, the more distal N1 motif at 147 in a
COL2A1 promoter-luciferase reporter construct was mutated to
test its function in the RCS cell line in which strong COL2A1
expression is normally observed. This mutational analysis in-
volved deletion of the four most conserved bases from the N1
motif (CCAGTGCCC to CCA----CC) at the 147 position. De-
letion of these four core bases increased the basal COL2A1 pro-
moter activity in our reporter construct as measured by relative
luciferase activity (Fig. 7A), suggesting that this is probably a
motif that binds to a repressor resulting in negative regulation. As
IL1B is known to repress chondrogenesis, the response of the
mutated COL2A1 promoter was also tested by measuring its re-
sponse to IL1B (Fig. 7A). As expected, the wild-type COL2A1 pro-
moter demonstrated a reduction in its basal activity (by 62%) in
the presence of IL1B. The mutant promoter activity was also re-
pressed (by 54%–63%), suggesting that the regulation to inflam-
matory mediators was still active. Interestingly, the repression of
the mutant promoter in the presence of IL1B results in its activity
being equal to the activity of the wild-type promoter in the ab-
sence of IL1B again, further suggesting that the 147 N1 motif
probably binds to a negatively regulating TF.
The functional significance of the N1 motifs found in the
promoter of an additional cartilage characteristic gene, COMP,
was also analyzed. When oligonucleotides representing an N1
motif in the COMP promoter were tested by EMSA as above, a
high-molecular-weight DNA–protein complex similar to that of
the other tested oligonucleotides was observed. This DNA–
protein complex was competed away with non-radiolabeled oli-
gonucleotides representing the wild-type N1 motif, but not by
oligonucleotides with mutation(s) of the core nucleotides within
the N1 motif (data not shown; for details, see Supplemental
Methods). Furthermore, to test the function of this motif in vitro,
analogous mutations in the human COMP gene promoter-
luciferase reporter construct were made, mutating the N1 se-
quence motif from CACCACAGCCC to CACTGTGGCCC to form
N1Mut (mutational changes are underlined) (Fig. 7B). The RCS
cell line transfected with this mutant construct also showed an
increase in activity compared to the wild-type promoter, again
demonstrating a negative transacting
cis-regulatory function for this motif.
Discussion
In this study, we have taken a computa-
tional approach to annotate and vali-
date important cis-regulatory motifs in
cartilage-specific genes. The use of stan-
dard molecular biology techniques such
as systematic sequence deletions and
other mutagenesis approaches to define
cartilage-specific regulatory regions
would have been time-consuming given
the size of the promoter region and the
number of genes that we have used in
this study. To circumvent this problem,
we used computational methods that
utilized position weight matrices and
phylogenetic footprinting to increase
the sensitivity of our predictions. Using this approach, we
screened our cartilage-specific gene set for previously character-
ized TF-binding motifs from the TRANSFAC database and novel
TF-binding sites with customized binding motifs. Statistical
Figure 6. Nuclear protein binding to predicted novel (N1) motifs. Electromobility gel shift assays
were performed to assess the ability of the motifs to bind proteins. Oligonucleotides (O1–O16) rep-
resenting motifs (mouse) identified within the cartilage gene set were radiolabeled with [32P]ATP,
incubated with nuclear extracts (NE) from rat chondrosarcoma cells, and the protein-binding moieties
were separated by SDS-PAGE (4%). In some reactions, additional unlabeled oligonucleotide (C) was
also added at 100 to evaluate specificity binding to the motifs. The presence or absence of nuclear
extract (NE) and unlabeled oligonucleotides (C) is indicated in the rows corresponding to the labels by
+ and , respectively. The radiolabeled oligonucleotides used in each reaction are indicated by lines
above the numbered oligonucleotide from Table 2. Predominant protein-binding complexes are in-
dicated by single and double arrowheads.
Figure 7. Mutation of the N1 motif increases basal promoter activity in
COL2A1 and COMP promoters. (A) RCS cells were transiently transfected
(in triplicate experiments) with either wild-type COL2A1 human promoter
(COL2A1-WT) or the mutated (COL2A1-N1Del) promoter-luciferase re-
porter constructs in the presence (+) or absence () of IL1B, to evaluate
the cis-regulatory function of the predicted N1 motif. The core sequence
(underlined) in the N1 motif (CCAGTGCCC) was deleted to CCA----CC.
(B) RCS cells were transfected with wild-type (COMP-WT) or mutant
(COMP-N1Mut) COMP luciferase-reporter promoter constructs (human).
The N1 motif in COMP promoter was converted from CACCACAGCCC to
CACTGTGGCCC to form N1Mut (the mutational changes are under-
lined). Luciferase activity was normalized as described in Methods.
Computational analysis of cartilage genes
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analysis of motif enrichment was performed to predict those that
are most likely to regulate the chondrocyte genes.
Several TRANSFAC motifs were highly represented in our
gene set for factors that play critical roles in patterning required
for skeletal development (Nissen et al. 2003), cartilage differen-
tiation (Inada et al. 1999; Miller et al. 2002), or cartilage gene
regulation (Takagi et al. 1998; Xie et al. 1998). AREB6 (encoded
by the gene ZEB1 and also called delta EF1), C/EBP, and possibly
other transcription factor motifs highly represented in our data
set are negative regulators of cartilage-specific gene expression
(Table 1B). In addition to down-regulation of the gene after the
tissue has been established, negative regulation may be particu-
larly relevant to tissue-specific genes in order to repress them in
all other tissues. Indeed, we have demonstrated that C/EBP is
responsible for suppression of Mia and COL2A1 in C2C12 muscle
cells in vitro, and potentially many other tissues in vivo (Okazaki
et al. 2006). This analysis, however, did not identify any high-
ranking SOX motifs despite the established importance of the
SOX5, SOX6, and SOX9 proteins in chondrogenesis (Lefebvre et
al. 2001). We used evolutionary conservation and the constraint
of the orientation and the distance between paired SOX sites to
refine our search further. This approach identified several highly
conserved SOX sites in the 15 cartilage-expressed genes (Supple-
mental Table 2). The potential function of paired SOX-binding
sites is supported by previous studies that have shown that co-
operative binding is important for SOX9 activity in cartilage. For
example, an inability of SOX9 to dimerize results in campomelic
dysplasia even though its other functions are unaltered (Sock et
al. 2003).
Using this information, we were able to refine our compu-
tational search and predict novel SOX-binding motifs for experi-
mental validation more reliably. We found many high-scoring
SOX-binding sites in our cartilage genes using the customized
SOX-binding profile, but only some of them were present in a
tandem pair with opposite orientations. We hypothesized that
this is the preferred architecture of the chondrocyte regulatory
module. Our analysis identified five novel SOX-binding motifs in
the COL9A1 promoter in addition to one that is already pub-
lished. Mutations in any of these SOX-binding motifs signifi-
cantly decreased promoter activity in luciferase reporter assays,
validating our computational approach. We also identified a
novel SOX-binding motif in the cartilage-specific Mia gene and
similarly validated its function by mutational analyses. Although
we did not test it for functional activity, our model also predicted
an additional SOX site (+130 bp), oppositely orientated and ad-
jacent to, a documented site (+120 bp) in the HAPLN1 gene (also
called cartilage linking protein 1 gene) (Kou and Ikegawa 2004)
that again supports the hypothesis that this is the preferred ar-
chitecture for the chondrocyte gene regulatory module.
Another challenge to defining biologically functional SOX-
binding sites through computational approaches is that in vivo,
some SOX sites function only in the context of other cis-acting
motifs and TFs (Kamachi et al. 2000). This is evident in chondro-
genesis, where SOX5 and SOX6 have been shown to synergisti-
cally activate the COL2A1 enhancer in collaboration with SOX9
(Lefebvre and de Crombrugghe 1998). This implies that although
a predicted SOX-binding motif could be a good match to the
binding profile, it may not be biologically functional. Our pre-
vious studies suggest that a C/EBP beta binding site may also be
a part of the chondrocyte regulatory module (Okazaki et al.
2006). C/EBP beta binding sites were found in close proximity to
the paired SOX binding sites in the enhancers of the Mia, Col2A1,
and Col11A2 genes (Fig. 2). When C/EBP beta sites were also
considered across the entire gene set, we found SOX-C/EBP beta
modules in the promoters of seven cartilage-specific genes
(Supplemental Table 2). In contrast, we found only two SOX-C/
EBP beta binding modules in 13 liver-expressed genes (Krivan
and Wasserman 2001) using these same search criteria (Supple-
mental Table 3). This suggests that our approach was reasonably
specific. Both of the two binding profiles used in this study, SOX
and C/EBP beta, are short and contain degeneracy in several po-
sitions. Therefore, without experimental validation, we cannot
say for certain that some of the identified paired SOX-binding
sites or C/EBP beta sites might not be false positives. Such a com-
prehensive understanding of the chondrocyte module may help
improve our computational predictions. For example, the perfor-
mance of our prediction may be improved by including binding
profiles of additional cooperative TFs in the chondrocyte regula-
tory modules. Although we have used this approach on cartilage-
specific genes, this general model could equally be applied to
other mammalian systems by adding in additional motifs with
known regulatory function (Fig. 8).
One drawback of performing computational promoter
analysis based on the TRANSFAC database is that currently we do
not have a complete collection of the binding profiles of all tran-
scription factors. Although recent studies have proposed meth-
ods to computationally identify mammalian TF-binding profiles
using comparative genomics approaches (Tan et al. 2005; Xie et
al. 2005), the latest version of TRANSFAC has only the weight
matrix models for about a quarter of the TFs in the human ge-
nome. Therefore, to identify enriched motifs in cartilage genes
that have not been found in TRANSFAC, we also applied DNA
pattern discovery algorithms on our cartilage gene set. Using this
computational approach, we were able to identify and validate
the function of one novel binding motif, N1, that appeared to
participate in regulating the basal promoter activity of the
COL2A gene. In addition to COL2A1, the N1 motif was also iden-
tified and validated in the promoter regions of other cartilage-
Figure 8. Proposed workflow of mammalian transcriptional regulatory
sequence identification (see text for discussion).
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expressed genes such as COMP and COL9A1 by mutational analy-
ses (data not shown), supporting its role as a cis-regulatory motif.
We do not know the identity of the factor that binds to N1, as it
does not correspond to any known TF-binding profile in the
TRANSFAC database or any cis-acting regulatory elements known
to drive cartilage-specific gene expression. Several N1 motifs were
close to or overlapping with previously identified binding sites
for SP1, EGR1 (Tan et al. 2003), or Maf (Huang et al. 2002).
However, we were not able to verify binding of any of these
proteins to the N1 motif using specific antibodies in gel shift
experiments (data not shown). Given that the mutation of the
motif appeared to increase basal promoter activity of several car-
tilage genes, it is likely that there is a repressive factor in RCS cells
that binds to this motif. The identity of the N1-binding protein
may be uncovered when the TRANSFAC database is more com-
plete.
In summary, there are several challenges in the use of com-
putational approaches to identify TF-binding motifs in mamma-
lian organisms. One major challenge is the fact that mammalian
species have very long intergenic sequence, and it is very difficult
to detect regulatory sequences in such a large search space. In our
approach, we used phylogenetic footprinting methods (Wasser-
man et al. 2000; Loots et al. 2002) and the constraints of the
orientation and the distance between binding sites within a regu-
latory module to refine the search of regulatory sequences. Using
an integration of multiple types of information indeed increases
the performance of the computational prediction. Our results
suggest that this appears to be particularly important for predict-
ing functional SOX or HMG motifs that have inherently high
degeneracy. Therefore, it is anticipated that the performance of
computational approaches will continue to improve when addi-
tional data sets or novel computational models become available.
This could include better evolutionary conservation models
based on a larger set of completely sequenced genomes, or a
better regulatory sequence analysis model that incorporates ad-
ditional sequence signals (e.g., chromosome remodeling). Mean-
while, combining computational and experimental methods
continues to be an advantageous approach, as they provide
complementary and valuable information and/or validation that
neither can achieve alone.
Methods
Definition of promoter sequences
A set of 18 orthologous human and mouse genes with docu-
mented expression in cartilage either during development or
maintenance of the tissue was selected for this analysis: ACAN,
CILP, COL11A1, COL11A2, COL2A1, COL9A1, COL9A2, COL9A3,
COMP, HAPLN1, CTGF, FGF18, IHH, MATN1, MATN3, MIA
(Cdrap), PRG4, and SOX9. An additional set of 13 previously
reported liver-specific genes was also collected for testing speci-
ficity. The promoter sequences from these gene sets were selected
for the analyses as follows. For most genes, the promoter se-
quence was defined as the 10-kb upstream and the 5-kb down-
stream sequence according to the transcriptional start site. For
some genes, the promoter sequence was truncated when an up-
stream gene was encountered (e.g., the COL11A2 gene) or when
the translation start site was reached. Focusing on the 15-kb ge-
nomic sequence around the transcription start site for each
gene in our analysis is keeping within the limit of current DNA
recognition pattern programs. For each human gene, the
mouse ortholog was determined by the NCBI’s HomoloGene
database (http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?
db=homologene). The mouse ortholog was further verified for
the reciprocal best match of the protein sequences using
WU-BLAST (http://blast.wustl.edu/). Promoter sequences of hu-
man and mouse genes were retrieved from the UCSC genome
browser (http://www.genome.ucsc.edu). Repetitive elements in the
promoter sequences were masked by the program RepeatMasker
(http://www.repeatmasker.org) with the slow and sensitive mode.
Determination of conserved regions in promoters
The conserved sequence regions in human and mouse ortholo-
gous promoters were determined by sequence alignment. Human
and mouse promoters were aligned using WU-BLAST with a cus-
tomized scoring matrix that considers the transition and the
transversion rates and the background base frequencies esti-
mated using all human and mouse promoters. This scoring ma-
trix was designed to search for local alignments of an average of
60% sequence identity. The “-link” parameter of WU-BLAST was
used to find the highest-scoring set of consistent alignments.
Identification of evolutionarily conserved TF-binding motifs
The program PATSER (Stormo et al. 1982) was used to search 436
vertebrate-specific weight matrix models collected from the
TRANSFAC 7.2 database (Wingender et al. 1996; Matys et al.
2003) in the cartilage gene promoters. A short stretch of sequence
was identified as a putative binding site of a TF if its score was
higher than the cutoff score calculated by PATSER (Staden 1989).
Both strands of the sequence were searched in our analysis. Only
binding sites that were conserved in both human and mouse
promoters according to the sequence alignment were deemed
conserved sites (Loots et al. 2002). Only conserved sites were used
in the following statistical analysis.
Enrichment of binding motifs
Assuming that the score of a weight matrix model is proportional
to the free energy of binding (Stormo and Fields 1998), the math-
ematical formula of the binding probability of a site and its score
has been described using the Boltzmann’s distribution (Stormo
2000). For a weight matrix of a factor F and a binding site x scored
s(x), the probability of F binding this site is given by
P = Aesx
where A is a factor-specific constant related to several aspects
including the binding specificity and the concentration of the
TF. Therefore, for a sequence having a set of binding sites, de-
noted by X, the probability score of the factor F binding to this
sequence via any of these sites is defined by (GuhaThakurta et al.
2002b)
P = 
x∈X
e sx
Given all the putative sites and their scores, one can calcu-
late the probability score of one factor binding to a set of pro-
moters by
Pgenes = 
i=1
N
Pi1N
To evaluate the over-representation of a transcription factor-
binding site in the cartilage promoters, the probability score
calculated using the cartilage promoters was compared to the
probability score calculated using the promoters of all 14,127
human genes. For each transcription factor binding site, a
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log(Pcartilage genes/Pall genes) [denoted by log(Pc/Pa)] value was cal-
culated. This value is a measure of the over-representation of the
binding sites of a transcription factor in the cartilage promoters
(GuhaThakurta et al. 2002b; Hu et al. 2004).
Construction of a cartilage-specific SOX-binding profile
To construct a model of SOX-binding motifs that is specific to
cartilage gene regulation, a set of 17 experimentally validated
SOX-binding sites from three cartilage-characteristic mouse
genes (Col2A1, Col11A2, and Mia) was collected (Supplemental
Table 1). Human and rat orthologs of these genes were identified
using the HomoloGene database, and genomic sequences of or-
thologous genes were aligned using the program WU-BLAST. Se-
quences in orthologous genes that were aligned to the experi-
mentally validated sites were identified and included in the list of
known SOX-binding sites. In this procedure, a total of 31 SOX-
binding sites were compiled and then used to build the SOX-
binding profile (Fig. 2A–C).
Identification of paired SOX-binding sites in cartilage genes
The conserved SOX-binding sites in cartilage promoters that are
conserved between human and mouse were identified using the
customized SOX-binding profile and the program PATSER
(Stormo et al. 1982) as described above. To identify paired SOX-
binding sites, the following criteria were applied: The spacer se-
quence between the two SOX sites is 3–8 bp, and the two SOX
sites in each pair must have opposite orientations.
Identification of novel regulatory motifs
in cartilage-characteristic genes
The DNA pattern recognition program CONSENSUS version 6C
(Hertz and Stormo 1999) was used to search for shared motifs in
the promoters of cartilage genes. Conserved sequences from hu-
man and mouse were searched separately on both strands of the
DNA. This process generated two sets of candidate motifs from
human and mouse. In both sets, motifs that were similar to char-
acterized transcription factor-binding profiles in TRANSFAC were
removed. Motifs that were similar to each other were also iden-
tified and merged by a dynamic programming algorithm using
ALLR as the scoring scheme (Wang and Stormo 2003). These
steps yielded a nonredundant list of novel regulatory motifs. The
two lists of novel motifs were compared, and motifs that are
shared in human and mouse were identified. We then searched
for these novel motifs in promoters of 14,127 human and mouse
orthologous gene pairs. The probability scores and the log(Pc/Pa)
were calculated as described above.
Cell culture
The LTC-rat chondrosarcoma cells (RCS) (Kucharska et al. 1990;
Mukhopadhyay et al. 1995; King and Kimura 2003) and mouse
3T3 embryo fibroblasts were used for in vitro functional testing
of motifs (see Supplemental Methods for detailed culture condi-
tions and preparation of nuclear extracts).
Electromobility gel shift assays (EMSA) and transient
transfections
Validation of functional activity of predicted motifs was deter-
mined using EMSA assays (see Supplemental Methods for experi-
mental details). Mutational analyses of the predicted SOX- or
N1-binding sites in the human COL9A1, COL2A1, COMP, and
mouse Mia promoters were further tested in transient transfec-
tion assays. Mutant constructs were created by using the
Quikchange Site-Directed Mutagenesis kit (Stratagene) (see
Supplemental Methods for primer sequences and details).
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